{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:28:02Z","timestamp":1790436482000,"version":"4.1.0"},"reference-count":30,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM109091"],"award-info":[{"award-number":["P20 GM109091"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>CDK8\/19 kinases, which mediate transcriptional reprogramming, have become an active target for cancer drug discovery. Several small-molecule CDK8\/19 inhibitors showed in vivo efficacy and two have entered clinical trials, with no significant toxicities reported. However, Clarke et al. (eLife 2016; 5; e20722) found severe systemic toxicity associated with two potent CDK8\/19 inhibitors, Cmpd3 (CCT251921) and Cmpd4 (MSC2530818), and suggested that their toxicity was due to on-target effects. Here, we compared five CDK8\/19 inhibitors: Cmpd3, Cmpd4, Senexin B, 16-didehydro-cortistatin A (dCA) and 15w, in different assays. Only Cmpd4 showed striking toxicity in developing zebrafish. In cell-based assays for CDK8 and CDK19 inhibition, Cmpd3, Cmpd4, dCA and 15w showed similar low-nanomolar potency and efficacy against CDK8 and CDK19, while Senexin B was less potent. Only dCA produced sustained inhibition of CDK8\/19-dependent gene expression. While toxicity of different compounds did not correlate with their effects on CDK8 and CDK19, kinome profiling identified several off-target kinases for both Cmpd3 and Cmpd4, which could be responsible for their toxicity. Off-target activities could have been achieved in the study of Clarke et al. due to high in vivo doses of Cmpd3 and Cmpd4, chosen for the ability to inhibit STAT1 S727 phosphorylation in tumor xenografts. We show here that STAT1 S727 phosphorylation is induced by various cytokines and stress stimuli in CDK8\/19-independent manner, indicating that it is not a reliable pharmacodynamic marker of CDK8\/19 activity. These results illustrate the need for careful off-target analysis and dose selection in the development of CDK8\/19 inhibitors.<\/jats:p>","DOI":"10.3390\/cells8111413","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T04:07:07Z","timestamp":1573531627000},"page":"1413","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Systemic Toxicity Reported for CDK8\/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition"],"prefix":"10.3390","volume":"8","author":[{"given":"Mengqian","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zansh\u00e9 S.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, College of Engineering and Computing, University of South Carolina, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Kathrein","sequence":"additional","affiliation":[{"name":"Department of Biology, University of South Carolina, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia V.","family":"Broude","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-1327","authenticated-orcid":false,"given":"Igor B.","family":"Roninson","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Philip, S., Kumarasiri, M., Teo, T., Yu, M., and Wang, S. (2018). Cyclin-Dependent kinase 8: A new hope in targeted cancer therapy?. J. Med. Chem., 10.","DOI":"10.1021\/acs.jmedchem.7b00901"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/trns.1.1.12373","article-title":"CDK8: A positive regulator of transcription","volume":"1","author":"Galbraith","year":"2010","journal-title":"Transcription"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/21541264.2018.1556915","article-title":"Regulatory functions of the Mediator kinases CDK8 and CDK19","volume":"10","author":"Fant","year":"2019","journal-title":"Transcription"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Roninson, I.B., Gyorffy, B., Mack, Z.T., Shtil, A.A., Shtutman, M.S., Chen, M., and Broude, E.V. (2019). Identifying cancers impacted by CDK8\/19. Cells, 8.","DOI":"10.3390\/cells8080821"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.1710467114","article-title":"CDK8\/19 mediator kinases potentiate induction of transcription by NFkappaB","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1158\/0008-5472.CAN-18-1583","article-title":"CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases","volume":"78","author":"Liang","year":"2018","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1038\/s41388-018-0316-y","article-title":"Mediator kinase CDK8\/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer","volume":"37","author":"Serrao","year":"2018","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13799","DOI":"10.1073\/pnas.1206906109","article-title":"Cyclin-Dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities","volume":"109","author":"Porter","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12558","DOI":"10.18632\/oncotarget.14894","article-title":"Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer","volume":"8","author":"McDermott","year":"2017","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature14904","article-title":"Mediator kinase inhibition further activates super-enhancer-associated genes in AML","volume":"526","author":"Pelish","year":"2015","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33779","DOI":"10.18632\/oncotarget.16810","article-title":"SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains","volume":"8","author":"Rzymski","year":"2017","journal-title":"Oncotarget"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.18632\/oncotarget.24414","article-title":"CDK8\/19 inhibition induces premature G1\/S transition and ATR-dependent cell death in prostate cancer cells","volume":"9","author":"Nakamura","year":"2018","journal-title":"Oncotarget"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Clarke, P.A., Ortiz-Ruiz, M.J., TePoele, R., Adeniji-Popoola, O., Box, G., Court, W., Czasch, S., El Bawab, S., Esdar, C., and Ewan, K. (2016). Assessing the mechanism and therapeutic potential of modulators of the human mediator complex-associated protein kinases. eLife, 5.","DOI":"10.7554\/eLife.20722"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/jm501436m","article-title":"Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen","volume":"58","author":"Mallinger","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/acs.jmedchem.5b01685","article-title":"Discovery of potent, selective, and orally bioavailable small-molecule modulators of the mediator complex-associated kinases CDK8 and CDK19","volume":"59","author":"Mallinger","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Czodrowski, P., Mallinger, A., Wienke, D., Esdar, C., Poeschke, O., Busch, M., Rohdich, F., Eccles, S.A., Ortiz Ruiz, M.J., and Schneider, R. (2016). Structure-Based optimization of potent, selective and orally bioavailable CDK8 inhibitors discovered by high throughput screening. J. Med. Chem.","DOI":"10.1021\/acs.jmedchem.6b00597"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Amirhosseini, M., Bernhardsson, M., Lang, P., Andersson, G., Flygare, J., and Fahlgren, A. (2019). Cyclin-Dependent kinase 8\/19 inhibition suppresses osteoclastogenesis by downregulating RANK and promotes osteoblast mineralization and cancellous bone healing. J. Cell. Physiol.","DOI":"10.1002\/jcp.28321"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Li, J., Ji, H., Porter, D.C., Broude, E.V., Roninson, I.B., and Chen, M. (2019). Characterizing CDK8\/19 inhibitors through a NFkB-dependent cell-based assay. Cells, 8.","DOI":"10.3390\/cells8101208"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bmc.2013.01.071","article-title":"Discovery and structure-activity relationship of thienopyridine derivatives as bone anabolic agents","volume":"21","author":"Saito","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1002\/anie.200901116","article-title":"Stereodivergent synthesis of 17-alpha and 17-beta-alpharyl steroids: Application and biological evaluation of D-ring cortistatin analogues","volume":"48","author":"Shi","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1002\/anie.200904778","article-title":"Cortistatin A is a high-affinity ligand of protein kinases ROCK, CDK8, and CDK11","volume":"48","author":"Cee","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfy044","article-title":"Making waves: New developments in toxicology with the zebrafish","volume":"163","author":"Horzmann","year":"2018","journal-title":"Toxicol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1242\/jcs.03153","article-title":"The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport","volume":"119","author":"Rutherford","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","article-title":"CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response","volume":"38","author":"Bancerek","year":"2013","journal-title":"Immunity"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/acsmedchemlett.5b00278","article-title":"Development of a potent, specific CDK8 kinase inhibitor which phenocopies CDK8\/19 knockout cells","volume":"7","author":"Koehler","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.celrep.2013.07.012","article-title":"CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance","volume":"4","author":"Putz","year":"2013","journal-title":"Cell Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/0192623314544468","article-title":"Preclinical toxicity of AZD7969: Effects of GSK3beta inhibition in adult stem cells","volume":"43","author":"Hall","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-15-2240","article-title":"Molecular pathways: Revisiting glycogen synthase kinase-3beta as a target for the treatment of cancer","volume":"23","author":"Walz","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_30","first-page":"e24275","article-title":"CDK8 as the STAT1 serine 727 kinase?","volume":"2","author":"Staab","year":"2013","journal-title":"JAKSTAT"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/11\/1413\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:33:10Z","timestamp":1760189590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/11\/1413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["cells8111413"],"URL":"https:\/\/doi.org\/10.3390\/cells8111413","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,9]]}}}